| 1 |
22134502 | MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer. | 2012 Mar |
1 |
| 2 |
19954744 | Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma. | 2010 Feb 3 |
1 |
| 3 |
19996219 | Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells. | 2009 Dec 15 |
1 |
| 4 |
18618574 | Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. | 2008 Aug 15 |
1 |
| 5 |
17363597 | A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. | 2007 Mar 15 |
1 |
| 6 |
16478747 | Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. | 2006 Feb 15 |
1 |
| 7 |
16818855 | Association of breast cancer outcome with status of p53 and MDM2 SNP309. | 2006 Jul 5 |
2 |
| 8 |
16141004 | The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. | 2005 Sep |
1 |